Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models-Reference-Cited by-同舟云学术

Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models

Published:2022-07 Issue: Volume:926 Page:175029
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Su Yunfang,Liu Ningning,Zhang Zijuan,Li Hao,Ma Jinlian,Yuan Ye,Shi Ming,Liu Jihong,Zhao Zhenrong,Zhang Zhenqiang,Holscher Christian

Publisher

Elsevier BV

Subject

Pharmacology

Reference43 articles.

1. BDNF and Netrin-1 repression by C/EBPbeta in the gut triggers Parkinson's disease pathologies, associated with constipation and motor dysfunctions;Ahn;Prog. Neurobiol.,2021

2. Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide- PD trial;Athauda;JAMA Neurol.,2019

3. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo- controlled trial;Athauda;Lancet,2017

4. Diagnostic utility of gut alpha-synuclein in Parkinson's disease: a systematic review and meta-analysis;Bu;Behav. Brain Res.,2019

5. Gut-brain connection: the neuroprotective effects of the anti-diabetic drug liraglutide;Candeias;World J. Diabetes,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liangxue Tongyu prescription attenuates neuroinflammation by increasing cholecystokinin octapeptide in acute intracerebral hemorrhage rats;Neuropeptides;2024-10

2. The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson’s Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2;Neurochemical Research;2024-08-27

3. The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review;Current Issues in Molecular Biology;2024-04-26

4. Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease;Frontiers in Neuroendocrinology;2024-04

5. Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions;International Journal of Molecular Sciences;2024-02-01